CAS: 914088-09-8 - Brentuximab vedotin
Formula:Unspecified
- Synonyms:
- cAC10-vcMMAE
- Brentuximab vedotin
- SGN 35
- Immunoglobulin G1, anti-(human CD30 (antigen)) (human-mouse monoclonal cAC10 γ1-chain), disulfide with human-mouse monoclonal cAC10 κ-chain, dimer, complex with N-[[[4-[[N-[6-(2,5-dihydro-2,5-dioxo-1H-pyrrol-1-yl)-1-oxohexyl]-L-valyl-N5-(aminocarbonyl)-L-ornithyl]amino]phenyl]methoxy]carbonyl]-N-methyl-L-valyl-N-[(1S,2R)-4-[(2S)-2-[(1R,2R)-3-[[(1R,2S)-2-hydroxy-1-methyl-2-phenylethyl]amino]-1-methoxy-2-methyl-3-oxopropyl]-1-pyrrolidinyl]-2-methoxy-1-[(1S)-1-methylpropyl]-4-oxobutyl]-N-methyl-L-valinamide
- CAC10-vcMMAE
| Brand | Product data | Purity | Price range | Estimated delivery |
|---|---|---|---|---|
 | Brentuximab vedotin REF: TM-T76707CAS: 914088-09-8 | 95% - 97.73% (SEC-HPLC) | 386.00 €~1,824.00 € | Wed 04 Dec 24 |
 | Brentuximab vedotin REF: 3D-CLA1034CAS: 914088-09-8 | - - - | 1,484.00 €~4,637.00 € | Fri 27 Dec 24 |
Brentuximab vedotin
CAS:914088-09-8
Brentuximab vedotin (SGN-35) is an antibody-activated molecule coupling (ADC) targeting CD30 with antitumor activity for …
Purity:
95% - 97.73% (SEC-HPLC)
Color and Shape:
Solid
Molecular weight:
145.58 kDa
Ref: TM-T76707
| 1mg | 386.00 € | ||
| 5mg | 927.00 € | ||
| 25mg | 1,824.00 € |
Estimated delivery in United States, on Wednesday 4 Dec 2024
Brentuximab vedotin
CAS:914088-09-8
Antibody-drug conjugate (ADC) comprising an anti-CD30 antibody and the cytotoxic agent Monomethyl auristatin E (MMAE).
Ref: 3D-CLA1034
| 1mg | 1,484.00 € | ||
| 5mg | 2,898.00 € | ||
| 10mg | 4,637.00 € |
Estimated delivery in United States, on Friday 27 Dec 2024
